Clinical pipeline advanced, with key Phase 3 trials in major depressive disorder and new studies entering clinic. These 10 stocks could mint the next wave of millionaires › Neumora Therapeutics ...

A health ministry panel Wednesday approved a plan to cut the price of Lecanemab, an Alzheimer's drug codeveloped by Japanese ...

Doctors are exploring an old, affordable diabetes drug as a possible way to help prevent dementia using real-world data from ...

WASHINGTON (AP) — So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using ...

Researchers say the new concept that lithium deficiency could be a cause of Alzheimer’s disease points to a different ...

Air pollution doesn’t just harm the lungs and heart—it may also damage the brain and increase the risk of serious ...

In mice, lithium depletion accelerated brain pathology and memory decline, Yankner and colleagues showed. Feeding wild-type and Alzheimer's mouse models a lithium-deficient diet reduced endogenous ...

New evidence of effectiveness is cause to drop a Biden restriction on Medicare coverage for anti-amyloid treatments.

Researchers at Harvard Medical School in Boston say that, based on a study in mice, lithium could someday help treat ...

Years of investigation by scientists at Harvard has revealed that lithium is deeply involved in Alzheimer’s disease, a ...

A study has identified a key disruption in cholesterol transport to the brain in patients with Alzheimer's disease. The findings suggest that the lipoproteins in the cerebrospinal fluid of patients ...